Your browser doesn't support javascript.
loading
Immunogenetic polymorphisms predict therapeutic efficacy and survival outcomes in tumor patients receiving PD-1/PD-L1 blockade.
Xin, Zhaodan; You, Liting; Li, Jin; Na, Feifei; Chen, Min; Song, Jiajia; Bai, Ling; Chen, Hao; Zhai, Jianzhao; Zhou, Xiaohan; Zhou, Juan; Ying, Binwu.
Affiliation
  • Xin Z; Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan Province 610041, PR China.
  • You L; Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan Province 610041, PR China; Laboratory of Aging Research and Cancer Drug Target, State Key Laboratory of Biotherapy, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University,
  • Li J; Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan Province 610041, PR China.
  • Na F; Department of Thoracic Cancer, West China Hospital, Sichuan University, Chengdu, Sichuan Province 610041, PR China.
  • Chen M; Department of Laboratory Medicine, The First Affiliated Hospital of Hainan Medical College, Haikou, Hainan Province 570102, PR China.
  • Song J; Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan Province 610041, PR China.
  • Bai L; Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan Province 610041, PR China.
  • Chen H; Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan Province 610041, PR China.
  • Zhai J; Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan Province 610041, PR China.
  • Zhou X; Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan Province 610041, PR China.
  • Zhou J; Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan Province 610041, PR China. Electronic address: zhoujuan39@wchscu.cn.
  • Ying B; Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan Province 610041, PR China. Electronic address: yingbinwu@scu.edu.cn.
Int Immunopharmacol ; 121: 110469, 2023 Aug.
Article de En | MEDLINE | ID: mdl-37311357
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Carcinome pulmonaire non à petites cellules / Antinéoplasiques immunologiques / Tumeurs du poumon Type d'étude: Prognostic_studies / Risk_factors_studies Limites: Humans Langue: En Journal: Int Immunopharmacol Sujet du journal: ALERGIA E IMUNOLOGIA / FARMACOLOGIA Année: 2023 Type de document: Article Pays de publication: Pays-Bas
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Carcinome pulmonaire non à petites cellules / Antinéoplasiques immunologiques / Tumeurs du poumon Type d'étude: Prognostic_studies / Risk_factors_studies Limites: Humans Langue: En Journal: Int Immunopharmacol Sujet du journal: ALERGIA E IMUNOLOGIA / FARMACOLOGIA Année: 2023 Type de document: Article Pays de publication: Pays-Bas